A Community Forum: Supporting Affordable Access to Long-Acting Injectable Cabotegravir (CAB-LA) took place in Kampala, Uganda from June 21-23, 2022.
Presentations, discussions, and panel sessions on the first two days of the meeting covered key focal areas across the product introduction pathway to inform a third and final day of work-planning and advocacy strategy development. This resource provides an overview of the meeting, including the background on why it was vital, important issues discussed, and key next steps to drive access to CAB-LA forward.